Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

Angiogenesis in cancer and other diseases

Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070

Coronary Plaque Disruption

Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539

Molecular Bases of the Acute Coronary Syndromes

Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839

The Coxibs, Selective Inhibitors of Cyclooxygenase-2

FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439

Coronary Plaque Erosion Without Rupture Into a Lipid Core: A Frequent Cause of Coronary Thrombosis in Sudden Coronary Death

Farb, A., Burke, A. P., Tang, A. L., Liang, Y., Mannan, P., Smialek, J., & Virmani, R. (1996) · Circulation · doi:10.1161/01.cir.93.7.1354 · Cited by 1,276

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214

Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.

Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,141

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.

Davies, M. J., Richardson, P. D., Woolf, N., Katz, D. R., & Mann, J. (1993) · Heart · doi:10.1136/hrt.69.5.377 · Cited by 1,127

Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease

Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,097

Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease

&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization

Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966

Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

Walter, D. H., Rittig, K., Bahlmann, F. H., Kirchmair, R., Silver, M., Murayama, T., Nishimura, H., Losordo, D. W., Asahara, T., & Isner, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000018166.84319.55 · Cited by 918

Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995

Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868

Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J., Sánchez-Pascuala, R., Hernández, G., Díaz, C., & Lamas, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1500 · Cited by 763

Vascular endothelial growth factor enhances atherosclerotic plaque progression

Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708

Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice

Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688

Statins Have Biphasic Effects on Angiogenesis

Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P. (2002) · Circulation · doi:10.1161/hc0602.103393 · Cited by 680

Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques

Sukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

Galis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E., Unemori, E. N., Lark, M. W., Amento, E., & Libby, P. (1994) · Circulation Research · doi:10.1161/01.res.75.1.181 · Cited by 646

Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

Geng, Y., & Libby, P. (1995) · Europe PMC (PubMed Central) · Cited by 640

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609

PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.

Egashira, K., Hirooka, Y., Kai, H., Sugimachi, M., Suzuki, S., Inou, T., & Takeshita, A. (1994) · Circulation · doi:10.1161/01.cir.89.6.2519 · Cited by 597

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G., & Humphries, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8154 · Cited by 590

An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro

Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588

Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit Atheroma: A Potential Mechanism of Lesion Stabilization

Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.97.24.2433 · Cited by 555

Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis

Hernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494

Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40: Induction of Collagenase, Stromelysin, and Tissue Factor

Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493

Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy

Rocha, R. (2000) · Endocrinology · doi:10.1210/en.141.10.3871 · Cited by 475

Requirement for CD154 in the progression of atherosclerosis

Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

Bustos, C., Hernández-Presa, M. A., Ortego, M., Tuñón, J., Ortega, L., Pérez, F., Díaz, C., Hernández, G., & Egido, J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00487-2 · Cited by 422

Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

Sparrow, C. P., Burton, C. A., Hernandez, M., Mundt, S., Hassing, H., Patel, S., Rosa, R., Hermanowski-Vosatka, A., Wang, P.-R., Zhang, D., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.115 · Cited by 413

TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages

Sarén, P., Welgus, H. G., & Kovanen, P. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4159 · Cited by 406

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

SGalis, Z., MMuszynski, KSukhova, G., ESimon-Morrissey, NUnemori, E., WLark, M., EAmento, & PLibby (1994) · Circulation Research · Cited by 402

Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis

Nikkari, S. T., O’Brien, K. D., Ferguson, M., Hatsukami, T., Welgus, H. G., Alpers, C. E., & Clowes, A. W. (1995) · Circulation · doi:10.1161/01.cir.92.6.1393 · Cited by 396

Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S., Wakino, S., Noh, G., Palinski, W., Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.3.365 · Cited by 385

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356

Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma: A Novel Collagenolytic Pathway Suggested by Transcriptional Profiling

Herman, M. P., Sukhova, G. K., Libby, P., Gerdes, N., Tang, N., Horton, D. B., Kilbride, M., Breitbart, R. E., Chun, M., & Schönbeck, U. (2001) · Circulation · doi:10.1161/hc4101.097419 · Cited by 348

Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.

Aikawa, M., Sivam, P. N., Kuro-o, M., Kimura, K., Nakahara, K., Takewaki, S., Ueda, M., Yamaguchi, H., Yazaki, Y., & Periasamy, M. (1993) · Circulation Research · doi:10.1161/01.res.73.6.1000 · Cited by 339

PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis

Marx, N., Kehrle, B., Kohlhammer, K., Grüb, M., Koenig, W., Hombach, V., Libby, P., & Plutzky, J. (2002) · Circulation Research · doi:10.1161/01.res.0000014225.20727.8f · Cited by 331

Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice: Pleiotropic Effects on CD36 Expression and HDL

Chen, Z., Ishibashi, S., Perrey, S., Osuga, J.-I., Gotoda, T., Kitamine, T., Tamura, Y., Okazaki, H., Yahagi, N., Iizuka, Y., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.3.372 · Cited by 320

Double-Edged Role of Statins in Angiogenesis Signaling

Urbich, C., Dernbach, E., Zeiher, A. M., & Dimmeler, S. (2002) · Circulation Research · doi:10.1161/01.res.0000014081.30867.f8 · Cited by 305

Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe

HACKETT, D., DAVIES, G., & MASERI, A. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062449 · Cited by 292

In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products

Diomede, L., Albani, D., Sottocorno, M., Donati, M. B., Bianchi, M., Fruscella, P., & Salmona, M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.094222 · Cited by 246

HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells

ToddBourcier, & PeterLibby (2000) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 233

George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.

Blankenhorn, D. H., & Hodis, H. N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.177 · Cited by 224

HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells

Bourcier, T., & Libby, P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.556 · Cited by 222

Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering

Wilson, S. H., Herrmann, J., Lerman, L. O., Holmes, D. R., Napoli, C., Ritman, E. L., & Lerman, A. (2002) · Circulation · doi:10.1161/hc0402.104119 · Cited by 221

Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma

Aikawa, M., Sugiyama, S., Hill, C. C., Voglic, S. J., Rabkin, E., Fukumoto, Y., Schoen, F. J., Witztum, J. L., & Libby, P. (2002) · Circulation · doi:10.1161/01.cir.0000028465.52694.9b · Cited by 204

PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages

Neve, B. P., Corseaux, D., Chinetti, G., Zawadzki, C., Fruchart, J.-C., Duriez, P., Staels, B., & Jude, B. (2001) · Circulation · doi:10.1161/01.cir.103.2.207 · Cited by 191

Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.

Brogi, E., Winkles, J. A., Underwood, R., Clinton, S. K., Alberts, G. F., & Libby, P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116847 · Cited by 190

PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes

Marx, N., Mackman, N., Schönbeck, U., Yilmaz, N., Hombach, V., Libby, P., & Plutzky, J. (2001) · Circulation · doi:10.1161/01.cir.103.2.213 · Cited by 175

Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering

Wilson, S. H., Simari, R. D., Best, P. J. M., Peterson, T. E., Lerman, L. O., Aviram, M., Nath, K. A., Holmes, D. R., & Lerman, A. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.122 · Cited by 166

Cell Composition, Replication, and Apoptosis in Atherosclerotic Plaques After 6 Months of Cholesterol Withdrawal

Kockx, M. M., De Meyer, G. R. Y., Buyssens, N., Knaapen, M. W. M., Bult, H., & Herman, A. G. (1998) · Circulation Research · doi:10.1161/01.res.83.4.378 · Cited by 165

Dietary Lipid Lowering Reduces Tissue Factor Expression in Rabbit Atheroma

Aikawa, M., Voglic, S. J., Sugiyama, S., Aïkawa, E., Taubman, M. B., Fallon, J. T., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.100.11.1215 · Cited by 141

The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits

Bocan, T. M. A., Krause, B. R., Rosebury, W. S., Mueller, S. B., Lu, X., Dagle, C., Major, T. C., Lathia, C. D., & Lee, H. H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.70 · Cited by 112

Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells

Lopez, S., Peiretti, F., Bonardo, B., Juhan-Vague, I., & Nalbone, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00454-8 · Cited by 110

Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect

Smith, D., Unger, A., Shao, J., Meraj, P., Fier, C., Cohen, A., Fallon, J., Badimon, J., Ambrose, J., & Dangas, G. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613893 · Cited by 103

Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor

YANAGI, H., SASAGURI, Y., Sugama, K., MORLMATSU, M., & Nagase, H. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90168-3 · Cited by 91

Vulnerable Atherosclerotic Plaque Morphology in Apolipoprotein E–Deficient Mice Unable to Make Ascorbic Acid

Nakata, Y., & Maeda, N. (2002) · Circulation · doi:10.1161/01.cir.0000012142.69612.25 · Cited by 87

Pleiotropic effects of statins: do they matter?

Gotto, A. M., & Farmer, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00004 · Cited by 78

Risk-Reduction Therapy: The Challenge to Change

Smith, S. C. (1996) · Circulation · doi:10.1161/01.cir.93.12.2205 · Cited by 74

Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?

Comparato, C., Altana, C., Bellosta, S., Baetta, R., Paoletti, R., & Corsini, A. (2001) · PubMed · Cited by 48

Relationship Between Coronary Thrombosis and Myocardial Infarction.

Roberts, W. C. (1972) · PubMed · Cited by 26

Inflammation, Atherosclerosis, and Coronary Artery Disease

Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773

Pathophysiology of coronary artery disease

Libby, P., & Theroux, P. (2005) · Circulation · doi:10.1161/circulationaha.105.537878 · Cited by 1,965

Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy

Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262

KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis

Shankman, L. S., Gomez, D., Cherepanova, O. A., Salmon, M., Alencar, G. F., Haskins, R. M., Swiatlowska, P., Newman, A. A. C., Greene, E. S., Straub, A. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3866 · Cited by 1,218

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction

Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925